Gastric Cancer

TOKYO, JAPAN, March 23, 2026 Daiichi Sankyo has announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved...

CAMBRIDGE, UK, March 16, 2026 AstraZeneca has received European Commission approval for Imfinzi (durvalumab) as the first and only...

ROCKVILLE, MARYLAND, UNITED STATES — February 17, 2026 NovaBridge announced dosing of the first patient in its global, randomized...

Hong Kong / Shanghai | December 30, 2025 — HUTCHMED announced that China’s drug regulator has accepted the New...